Rong Yi, Chen Yu, Shang Lu, Zuo Li, Lu Weiguo, Chen Quan
Department of Radiation Oncology, The Ohio State University Wexner Medical Center, Columbus, Ohio 43210.
21st Century Oncology, Madison, Wisconsin 53719.
Med Phys. 2014 May;41(5):051709. doi: 10.1118/1.4870987.
Despite superior target dose uniformity, helical tomotherapy(®) (HT) may involve a trade-off between longitudinal dose conformity and beam-on time (BOT), due to the limitation of only three available jaw sizes with the conventional HT (1.0, 2.5, and 5.0 cm). The recently introduced dynamic running-start-stop (RSS) delivery allows smaller jaw opening at the superior and inferior ends of the target when a sharp penumbra is needed. This study compared the dosimetric performance of RSS delivery with the fixed jaw HT delivery.
Twenty patient cases were selected and deidentified prior to treatment planning, including 16 common clinical cases (brain, head and neck (HN), lung, and prostate) and four special cases of whole brain with hippocampus avoidance (WBHA) that require a high degree of dose modulation. HT plans were generated for common clinical cases using the fixed 2.5 cm jaw width (HT2.5) and WBHA cases using 1.0 cm (HT1.0). The jaw widths for RSS were preset with a larger size (RSS5.0 vs HT2.5 and RSS2.5 vs HT1.0). Both delivery techniques were planned based on identical contours, prescriptions, and planning objectives. Dose indices for targets and critical organs were compared using dose-volume histograms, BOT, and monitor units.
The average BOT was reduced from 4.8 min with HT2.5 to 2.5 min with RSS5.0. Target dose homogeneity with RSS5.0 was shown comparable to HT2.5 for common clinical sites. Superior normal tissue sparing was observed in RSS5.0 for optic nerves and optic chiasm in brain and HN cases. RSS5.0 demonstrated improved dose sparing for cord and esophagus in lung cases, as well as penile bulb in prostate cases. The mean body dose was comparable for both techniques. For the WBHA cases, the target homogeneity was significantly degraded in RSS2.5 without distinct dose sparing for hippocampus, compared to HT1.0.
Compared to the fixed jaw HT delivery, RSS combined with a larger jaw width provides faster treatment delivery and improved cranial-caudal target dose conformity. The target coverage achieved by RSS with a large jaw width is comparable to the fixed jaw HT delivery for common cancer sites, but may deteriorate for cases where complex geometry is present in the middle part of the target.
尽管螺旋断层放射治疗(HT)具有卓越的靶区剂量均匀性,但由于传统HT(1.0、2.5和5.0 cm)仅有三种可用的准直器尺寸限制,在纵向剂量适形性与照射时间(BOT)之间可能存在权衡。最近引入的动态启停(RSS)投照技术,在需要锐利半影时,可在靶区的上下两端采用更小的准直器开口。本研究比较了RSS投照技术与固定准直器HT投照技术的剂量学性能。
在治疗计划前选择并匿名处理了20例患者病例,包括16例常见临床病例(脑、头颈部(HN)、肺和前列腺)以及4例需要高度剂量调制的全脑避海马区(WBHA)特殊病例。对于常见临床病例,使用固定的2.5 cm准直器宽度生成HT计划(HT2.5),对于WBHA病例,使用1.0 cm准直器宽度生成HT计划(HT1.0)。RSS的准直器宽度预设为更大尺寸(RSS5.0对比HT2.5以及RSS2.5对比HT1.0)。两种投照技术均基于相同的轮廓、处方和计划目标进行规划。使用剂量体积直方图、BOT和监测单位比较靶区和关键器官的剂量指标。
平均BOT从HT2.5的4.8分钟减少至RSS5.0的2.5分钟。对于常见临床部位,RSS5.0的靶区剂量均匀性与HT2.5相当。在脑和HN病例中,RSS5.0对视神经和视交叉的正常组织保护更佳。在肺部病例中,RSS5.0对脊髓和食管以及前列腺病例中的阴茎球部的剂量保护有所改善。两种技术的平均体部剂量相当。对于WBHA病例,与HT1.0相比,RSS2.5的靶区均匀性显著下降,且对海马区无明显剂量保护。
与固定准直器HT投照相比,RSS结合更大的准直器宽度可实现更快的治疗投照并改善头脚方向的靶区剂量适形性。对于常见癌症部位,RSS采用大准直器宽度实现的靶区覆盖与固定准直器HT投照相当,但对于靶区中部存在复杂几何形状的病例可能会变差。